מנבאו

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

MENINGOCOCCAL VACCINES GROUP A; MENINGOCOCCAL VACCINES GROUP C; MENINGOCOCCAL VACCINES GROUP W; MENINGOCOCCAL VACCINES GROUP Y

Fáanlegur frá:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC númer:

J07AH02

Lyfjaform:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Samsetning:

MENINGOCOCCAL VACCINES GROUP Y 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP W 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP C 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP A 10 MCG / 0.5 ML

Stjórnsýsluleið:

תוך-שרירי

Gerð lyfseðils:

מרשם נדרש

Framleitt af:

GLAXO SMITHKLINE VACCINES S.R.L., ITALY

Meðferðarhópur:

OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN

Lækningarsvæði:

OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN

Ábendingar:

Menveo is indicated for active immunization of children (2 years of age and above), adolescents and adults up to the age of 55 years, at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease. The use of this vaccine should be in accordance with official recommendations.

Vörulýsing:

החיסון יינתן עבור חולה הלוקה באחד מאלה:1. אספלניה, היפוספלניה אנטומית או תפקודית, נרכשת או מולדת.2. חסר במערכת המשלים כגון חסר בפקטור D, פרופרידין ובמרכיב המשלים C5-9 או C3

Leyfisdagur:

2017-08-31